Clinical Trials Directory

Trials / Completed

CompletedNCT06632340

Effect of Tumor Base Size in Bladder Cancer

Effect of Tumor Base Size on Recurrence and Progression in Non-muscle Invasise Bladder Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
130 (actual)
Sponsor
Ankara Training and Research Hospital · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Investigators aim to investigate the effect of the size of the base of the tumor in contact with the bladder mucosa on recurrence and progression in non-muscle invasive bladder tumors.

Detailed description

Between March 2021 and September 2023, 130 patients who applied to our clinic with complaints of hematuria, dysuria, and suprapubic pain, and who were diagnosed with bladder tumor by imaging methods and underwent TUR-MT were included in the study. The groups were compared in terms of age, gender, smoking, ASA, comorbidities, BMI and the number of tumors, size, stage as intraoperative and postoperative data. Patients with tumor base size \<2 cm were classified as Group 1, while with tumor base size ≥2 cm were classified as Group 2. Kaplan Meier survival analysis without recurrence and without progression were performed after comparing the groups in terms of recurrence and progression.

Conditions

Interventions

TypeNameDescription
PROCEDURETUR-BTTransurethral resection of bladder tumor

Timeline

Start date
2021-03-01
Primary completion
2023-09-30
Completion
2024-01-01
First posted
2024-10-09
Last updated
2024-10-16

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT06632340. Inclusion in this directory is not an endorsement.